-
Enhanced reduced representation bisulfite sequencing (eRRBS) on 45 multiple myeloma samples and 3 normal plasma cell
Study
EGAS00001004348
-
Control samples, breast cancer clinical samples and matched patient-derived tumour xenografts (PDTXs) to develop and test a computational approach to discriminate human and mouse sequences in PDTXs
Study
EGAS00001002445
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Molecular characterization of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
Study
EGAS00001005222
-
Esophageal Adenocarcinoma Organoid Genomics
Study
EGAS00001005224
-
Hepatoblastoma tumoroid biobank as a key resource for tumour genetics
Study
EGAS00001008251
-
Combined clinical and gene expression score identifies high-risk individuals among follicular lymphoma patients on immunotherapy
Study
EGAS00001002566
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
Gene expression profiling of nasopharyngeal carcinoma
Study
EGAS00001004542
-
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
Study
EGAS00001004366
-
tFL with a PMBL GE signature
Study
EGAS00001005870
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Cerebrospinal fluid circulating tumour DNA allows the characterisation and monitoring of medulloblastoma
Study
EGAS00001004651
-
Multiple Myeloma Total Therapy trial patient sequencing
Study
EGAS00001003223
-
Patient-derived tumor organoids for personalized medicine in a rare case of hepatocellular carcinoma with neuroendocrine differentiation.
Study
EGAS00001005887
-
Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021
Study
EGAS00001004494
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Alveolar Rhabdomyosarcoma sequencing data
Study
EGAS00001005387
-
Single cell copy number and chromatin accessibility in primary multiple myeloma cells
Study
EGAS00001005382
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
A mechanistic classification of clinical phenotypes in neuroblastoma
Study
EGAS00001003244
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Characterizing the immune and genome landscapes for osteosarcoma
Study
EGAS00001003247
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastoma
Study
EGAS00001003251
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
CRISPR/Cas9-mediated genome editing of Schistosoma mansoni acetylcholinesterase
Study
EGAS00001004455
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Paired data of primary and relapse central nervous system lymphoma and testicular lymphoma
Study
EGAS00001005833
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients
Study
EGAS00001003255
-
Targeted-capture sequencing (bam files) of 81 samples of myxofibrosarcoma and 44 matched pairs
Study
EGAS00001005443
-
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
Study
EGAS00001005394
-
An epigenetic single-cell atlas of IDH-mutant glioma reveals the role of ATRX in shaping tumor composition
Study
EGAS00001004523
-
Changes in alternative splicing and associated neo-antigens due to therapy
Study
EGAS00001004524
-
CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)
Study
EGAS00001005501
-
Embryonal Rhabdomyosarcoma sequencing data
Study
EGAS00001005502
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Dynamic N6-methyladenosine Epitranscriptomic Landscape in Lung Adenocarcinoma
Study
EGAS00001005524
-
NLG-LBC-05 ctDNA
Study
EGAS00001005835
-
Microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma
Study
EGAS00001006052